Subscribe to RSS
DOI: 10.1055/a-2764-3235
Surgical Management of Filler Rhinoplasty Complications
Authors
Abstract
Aim and Background
The increasing use of filler rhinoplasty has led to more patients presenting with complications such as fibrosis, granuloma formation, skin irregularities, and filler migration, including the characteristic “Avatar nose.” These cases require a systematic, algorithm-driven approach for safe and predictable correction.
Historical Aspects
Nonsurgical rhinoplasty has gained popularity due to its minimally invasive nature, yet complications requiring surgery have become increasingly recognized.
Anatomy
Distorted soft-tissue planes and altered skin-soft-tissue envelopes (SSTE) after filler placement influence both dissection and reconstruction.
Technology
High-frequency ultrasound can assist in identifying residual filler and guiding hyaluronidase dissolution before surgery.
Patient Selection
Patients with persistent deformity, migration, granuloma, or long-standing fillers unresponsive to nonsurgical measures are appropriate surgical candidates.
Techniques
Revision rhinoplasty involves open approaches, selective removal of residual filler, and structural reconstruction with autologous cartilage. Redundant SSTE may require increased dorsal augmentation, conservative trimming, and adjunctive intraoperative doxycycline.
Postoperative Care
Postoperative corticosteroid injections can limit fibrosis and improve contour.
Current and Future Development
Algorithm-based evaluation and operative planning continue to refine management of these complex cases.
Conclusion and Clinical Relevance
Thoughtful surgical execution is essential for achieving stable, natural outcomes in patients with filler-related nasal complications.
Declaration of GenAI Use
During the writing of this article, the authors used ChatGPT to correct spelling, refine grammar, and format the text. The authors have reviewed and edited the content and take full responsibility for the final version of the article.
Publication History
Received: 19 November 2025
Accepted: 03 December 2025
Article published online:
18 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Al-Taie DS, AlEdani EM, Gurramkonda J. et al. Non-surgical rhinoplasty (NSR): a systematic review of its techniques, outcomes, and patient satisfaction. Cureus 2023; 15 (12) e50728
- 2 DeVictor S, Ong AA, Sherris DA. Complications secondary to nonsurgical rhinoplasty: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2021; 165 (05) 611-616
- 3 Jordan DR, Stoica B. Filler migration: a number of mechanisms to consider. Ophthalmic Plast Reconstr Surg 2015; 31 (04) 257-262
- 4 Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009; 123 (06) 1842-1863
- 5 Nguyen TA, Reddy S, Gharavi N. Specific complications associated with non-surgical rhinoplasty. J Cosmet Laser Ther 2020; 22 (4–5): 171-173
- 6 Song D, Wang X, Yu Z. Nonsurgical rhinoplasty: an updated systematic review of technique, outcomes, complications, and its treatments. Aesthetic Plast Surg 2024; 48 (23) 4902-4915
- 7 Mundada P, Kohler R, Boudabbous S, Toutous Trellu L, Platon A, Becker M. Injectable facial fillers: imaging features, complications, and diagnostic pitfalls at MRI and PET CT. Insights Imaging 2017; 8 (06) 557-572
- 8 Chai H, Su X, Yuan L. et al. Application of high-frequency ultrasound in detection and identification of nasal filling injection materials. J Cosmet Dermatol 2022; 21 (10) 4276-4287
- 9 Angelo-Khattar M. Objective assessment of the long-term volumizing action of a polycaprolactone-based filler. Clin Cosmet Investig Dermatol 2022; 15: 2895-2901
- 10 Lin SL, Christen MO. Polycaprolactone-based dermal filler complications: a retrospective study of 1111 treatments. J Cosmet Dermatol 2020; 19 (08) 1907-1914
- 11 Lorenc ZP, Black JM, Cheung JS. et al. Skin tightening with hyperdilute caha: Dilution practices and practical guidance for clinical practice. Aesthet Surg J 2022; 42 (01) NP29-NP37
- 12 Qureshi KI, Vercesi F, Qureshi HF. Rhinomodelation with polycarpolactone-a safer and effective solution for the future. J Cosmet Dermatol 2025; 24 (02) e70001
- 13 Kim JS. Changes in dermal thickness in biopsy study of histologic findings after a single injection of polycaprolactone-based filler into the dermis. Aesthet Surg J 2019; 39 (12) NP484-NP494
- 14 Schelke LW, Van Den Elzen HJ, Erkamp PP, Neumann HA. Use of ultrasound to provide overall information on facial fillers and surrounding tissue. Dermatol Surg 2010; 36 (Suppl. 03) 1843-1851
- 15 Wortsman X, Quezada N. Ultrasound morphology of polycaprolactone filler. J Ultrasound Med 2017; 36 (12) 2611-2615
- 16 Hexsel D, de Morais MR. Management of complications of injectable silicone. Facial Plast Surg 2014; 30 (06) 623-627
- 17 Grippaudo FR, Mattei M. The utility of high-frequency ultrasound in dermal filler evaluation. Ann Plast Surg 2011; 67 (05) 469-473
- 18 Singh P, Vijayan R, Nikkhah D. Filler rhinoplasty: evidence, outcomes, and complications. Aesthet Surg J 2018; 38 (11) NP165-NP167
- 19 Robati RM, Moeineddin F, Almasi-Nasrabadi M. The risk of skin necrosis following hyaluronic acid filler injection in patients with a history of cosmetic rhinoplasty. Aesthet Surg J 2018; 38 (08) 883-888
- 20 Burt B, Nakra T, Isaacs DK, Goldberg RA. Alar necrosis after facial injection of hyaluronic Acid. Plast Reconstr Surg 2010; 125 (05) 199e-200e
- 21 Kang MS, Park ES, Shin HS, Jung SG, Kim YB, Kim DW. Skin necrosis of the nasal ala after injection of dermal fillers. Dermatol Surg 2011; 37 (03) 375-380
- 22 Lichtenberg NJ, Otte NJ, Choa R. Fear ‘filled’ complication: intravascular hyaluronic acid filler injection and tissue necrosis. ANZ J Surg 2025; 95 (1–2): 257-259
- 23 Beleznay K, Carruthers JDA, Humphrey S, Carruthers A, Jones D. Update on avoiding and treating blindness from fillers: a recent review of the world literature. Aesthet Surg J 2019; 39 (06) 662-674
- 24 Doyon VC, Liu C, Fitzgerald R. et al. Update on blindness from filler: review of prognostic factors, management approaches, and a century of published cases. Aesthet Surg J 2024; 44 (10) 1091-1104
- 25 Kim H, Cho SH, Lee JD, Kim HS. Delayed onset filler complication: two case reports and literature review. Dermatol Ther 2017; 30 (05) 30
- 26 Wan J, Hong GW, Wu R. et al. Why does an “avatar nose” appear after dermal filler injection? Insights from a cadaveric study on the nasofrontal ligament. Dermatol Surg 2025; 51 (05) 493-496
- 27 Lee JM, Kim YJ. Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg 2015; 42 (02) 232-239
- 28 Goodman GJ, McDonald CB, Lim A. et al. Making sense of late tissue nodules associated with hyaluronic acid injections. Aesthet Surg J 2023; 43 (06) NP438-NP448
- 29 Wagner RD, Fakhro A, Cox JA, Izaddoost SA. Etiology, prevention, and management of infectious complications of dermal fillers. Semin Plast Surg 2016; 30 (02) 83-86
- 30 Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 2010; 125 (04) 1250-1256
- 31 King M. Management of tyndall effect. J Clin Aesthet Dermatol 2016; 9 (11) E6-E8
- 32 Maamari SA, Vansteelant G, Appan S, D'Souza A. Effect of facial fillers on post-rhinoplasty edema: A hypothesis based on literature review. Facial Plast Surg 2025; 41 (05) 689-694
- 33 Phondge V, Dornbrand-Lo M, Deshpande P, Wong AK. Beyond swelling: a review of postoperative lymphedema in aesthetic surgery. Lymphatics 2025; 3 (03) 26
- 34 Bachour Y, Bekkenk MW, Rustemeyer T, Kadouch JA. Late inflammatory reactions in patients with soft tissue fillers after SARS-CoV-2 infection and vaccination: a systematic review of the literature. J Cosmet Dermatol 2022; 21 (04) 1361-1368
- 35 Wang HC, Zhou X, Zheng D. Dermal filler hypersensitivity post-covid-19 illness: case series and literature review. Aesthetic Plast Surg 2024; 48 (04) 633-637
- 36 Bertossi D, Giampaoli G, Verner I, Pirayesh A, Nocini R, Nocini P. Complications and management after a nonsurgical rhinoplasty: a literature review. Dermatol Ther 2019; 32 (04) e12978
- 37 Cavallini M, Gazzola R, Metalla M, Vaienti L. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 2013; 33 (08) 1167-1174
- 38 Jung H. Hyaluronidase: an overview of its properties, applications, and side effects. Arch Plast Surg 2020; 47 (04) 297-300
- 39 Rao V, Chi S, Woodward J. Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers. J Drugs Dermatol 2014; 13 (09) 1053-1056
- 40 DeLorenzi C. Transarterial degradation of hyaluronic acid filler by hyaluronidase. Dermatol Surg 2014; 40 (08) 832-841
- 41 Paap MK, Silkiss RZ. The interaction between hyaluronidase and hyaluronic acid gel fillers - a review of the literature and comparative analysis. Plast Aesthet Res 2020; 7: 36
- 42 Bravo BSF, Cavalcante T, Silveira C, Bravo LG, Zafra MC, Elias MC. Resolve and dissolve-an ultrasound-guided investigation on the effects of hyaluronidase on different soft tissue fillers. J Cosmet Dermatol 2024; 23 (10) 3173-3181
- 43 Juhász MLW, Levin MK, Marmur ES. The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase. Dermatol Surg 2017; 43 (06) 841-847
- 44 Rauso R, Zerbinati N, Franco R. et al. Cross-linked hyaluronic acid filler hydrolysis with hyaluronidase: different settings to reproduce different clinical scenarios. Dermatol Ther 2020; 33 (02) e13269
- 45 Hong GW, Hu H, Wan J. et al. How should we use hyaluronidase for dissolving hyaluronic acid fillers?. J Cosmet Dermatol 2025; 24 (01) e16783
- 46 DeLorenzi C. New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J 2017; 37 (07) 814-825
- 47 Kim HJ, Kwon SB, Whang KU, Lee JS, Park YL, Lee SY. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection. J Cosmet Laser Ther 2018; 20 (01) 52-57
- 48 Lau E, Bohórquez JMC, Schelke L. et al. Persistent ha fillers and nasal broadening: role of ultrasound in managing “avatar nose.”. J Craniofac Surg 2025
- 49 Kim SG, Kim YJ, Lee SI, Lee CJ. Salvage of nasal skin in a case of venous compromise after hyaluronic acid filler injection using prostaglandin E. Dermatol Surg 2011; 37 (12) 1817-1819
- 50 Uittenbogaard D, Lansdorp CA, Bauland CG, Boonstra O. Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report. Undersea Hyperb Med 2019; 46 (02) 207-210
- 51 Artzi O, Cohen JL, Dover JS. et al. Delayed inflammatory reactions to hyaluronic acid fillers: A literature review and proposed treatment algorithm. Clin Cosmet Investig Dermatol 2020; 13: 371-378
- 52 He J, Bian W, Yang J, Dai T, Wei J. Surgical removal of foreign material by suction curettage after injection rhinoplasty: patient-reported outcomes. Aesthetic Plast Surg 2022; 46 (06) 2964-2971
- 53 Christen MO, Vercesi F. Polycaprolactone: how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Investig Dermatol 2020; 13: 31-48
- 54 Bravo BSF, de Melo Carvalho R, Souza E, Vargas TJS, Bravo LG. Ultrasound-guided poly-l-lactic acid nodule excision: the importance of the injector ultrasonographic experience. J Cosmet Dermatol 2021; 20 (02) 417-419
- 55 Honart JF, Duron JB, Mazouz Dorval S, Rausky J, Revol M. [A case of nasal tip necrosis after hyaluronic acid injection]. Ann Chir Plast Esthet 2013; 58 (06) 676-679
- 56 Plasen NST, Bunaprasert T. Correction of nasal skin necrosis after filler injection with micro and nanofat grafting. J Cutan Aesthet Surg 2025
- 57 Kim JH, Park SH, Lee BH, Jeong HS, Yang HJ, Suh IS. Early intervention with highly condensed adipose-derived stem cells for complicated wounds following filler injections. Aesthetic Plast Surg 2016; 40 (03) 428-434
- 58 Menick FJ. Aesthetic and reconstructive rhinoplasty: a continuum. J Plast Reconstr Aesthet Surg 2012; 65 (09) 1169-1174
- 59 You J, Wang S, Wang H, Fan F. Practical details of nasal reconstruction. Plast Reconstr Surg 2014; 133 (01) 71e
- 60 Staglianò S, Tartaro G, Bertossi D. et al. An Italian online survey regarding the use of hyaluronidase in previously hyaluronic acid-injected noses looking for surgical rhinoplasty. Aesthet Surg J Open Forum 2022; 4: ojac060
- 61 Kroumpouzos G, Treacy P. Hyaluronidase for dermal filler complications: Review of applications and dosage recommendations. JMIR Dermatol 2024; 7: e50403
- 62 Kadouch J, Schelke L, Groh O, Sokol V, Velthuis P. Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events. Int J Dermatol 2024; 63 (09) 1252-1255
- 63 Kovacevic M, Kosins AM, Davis R, Al Maamari S, D'Souza A. Doxycycline sclerodesis-“rhinodesis”-for enhanced soft tissue adhesion in rhinoplasty: a preliminary study. Facial Plast Surg 2024; 40 (05) 655-663
- 64 Beaudoin PL, Carles G. Template for diced cartilage with platelet-rich fibrin (prf) in rhinoplasty: an easy solution for millimetric camouflage of the full dorsal esthetic unit. Facial Plast Surg 2023; 39 (06) 707-713
- 65 Tang Y, Han X, Li J, Cao Y, Gong Y, Xu C. A systematic review of technique, satisfaction, and complications of acellular dermal matrix in rhinoplasty. J Craniofac Surg 2024;
- 66 Hanasono MM, Kridel RW, Pastorek NJ, Glasgold MJ, Koch RJ. Correction of the soft tissue pollybeak using triamcinolone injection. Arch Facial Plast Surg 2002; 4 (01) 26-30 , discussion 31
- 67 Wong TS, Li JZ, Chen S, Chan JY, Gao W. The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis. Front Med (Lausanne) 2016; 3: 71
